Publications

5808 Results

The final results of the SWOG S9304 phase III intergroup trial's pharmacogenetic analysis: association of polymorphisms with survival and toxicity in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation (RT)

Authors
PMD Wilson;PO Bohanes;C Rankin;J Benedetti;CM Ulrich;S Smalley;K Makar;W Zhang;T Winder;Y Ning;A Gerger;L Benhaim;R El-Khoueiry;M Labonte;CD Blanke;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 29:(suppl;abstr 3542); American Society of Clinical Oncology Annual Meeting, general poster;
Year
2011
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the Prostate Cancer Prevention Trial. PMID21540324

Authors
JM Schenk;AR Kristal;KB Arnold;C Tangen;M Neuhouser;DW Lin;E White;IM Thompson
Journal / Conference
American Journal of Epidemiology 173(12):1419-1428
Year
2011
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Cancer and Leukemia Group B pathology committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues [PMID21519016; PMC3107745]

Authors
D Rimm;T Nielsen;S Jewel;D Rohrer;G Broadwater;F Waldman;K Mitchell;B Singh;G Tsongalis;W Frankel;W Magliocco;J Lara;E Hsi;I Bleiweiss;S Badve;B Chen;P Ravdin;R Schilsky;A Thor;D Berry
Journal / Conference
Journal of Clinical Oncology 29(16):2282-2290
Year
2011
Research Committee(s)
Breast
Study Number(s)
C9741

Long-term follow-up of SWOG S0033, a phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GIST)

Authors
L Baker;C Rankin;C Blanke;G Demetri;J Crowley;R Benjamin;J Stevenson;M Blackstein;D Priebat;W Tap;M Von Mehren
Journal / Conference
Proc CTOS 2011:24, 2011 (abstr 105) Connective Tissue Oncology Society Annual Meeting , oral
Year
2011
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Long-term survival on S0033: a phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs)

Authors
C Blanke;C Rankin;R Benjamin;AK Raymond;M Heinrich;C Fletcher;J Crowley;EC Borden;G Demetri;L Baker
Journal / Conference
Proc ESMO 47:S664 2011 (abstr 9404) (European Society for Medical Oncology Annual Meeting, oral)
Year
2011
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 [PMID21135270; PMC3056462]

Authors
E Gore;S Wong;A Sun;JA Bonner;SC Schild;L Gaspar;JA Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):272-278
Year
2011
Research Committee(s)
Lung

Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. [PMID21135267; PMC3056463]

Authors
A Sun;K Bae;B Movsas;S Wong;CA Meyers;JA Bonner;SE Schild;L Gaspar;J Bogart;M Werner-Wasik;H Choy
Journal / Conference
Journal of Clinical Oncology 29(3):279-286
Year
2011
Research Committee(s)
Lung

A phase III randomized trial of anastrozole versus anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: SWOG S0226

Authors
R Mehta;W Barlow;K Albain;T Vandenberg;S Dakhil;N Tirumali;D Lew;D Hayes;J Gralow;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abst. S1-1;oral presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S0226

SWOG S0927: A randomized doubled blind placebo-controlled trial of omega-3-fatty acid for the control of aromatase inhibitor (AI)-induced musculoskeletal pain in women with early stage breast cancer

Authors
D Hershman;J Unger;K Crew;C Moinpour;L Minasian;L Hansen;D Lew;K Kaberle;J Wade;F Meyskens
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract OT2-07-02 (poster);
Year
2011
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0927

A randomized phase III clinical trial of standard adjuvant endocrine therapy in patients (pts) with 1-3 positive nodes, hormone receptor (HR)-positive and HER-2negative breast cancer with recurrence score (RS) of 25 or less: SWOG S1007

Authors
A Gonzalez-Angulo;W Barlow;J Gralow;F Meric-Bernstam;D Hayes;C Moinpour;S Ramsey;A Schott;D Sparks;K Albain;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium 2011 Meeting, abstract # OT1-03-01;poster presentation;
Year
2011
Research Committee(s)
Breast
Study Number(s)
S1007